Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0257 Transporter Info | ||||
Gene Name | SLC2A2 | ||||
Transporter Name | Glucose transporter type 2, liver | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Chemical Compound |
|||||
DT Modulation1 |
NR1I2 protein promotes the reaction Rifampin results in decreased expression of SLC2A2 protein | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
Catechin inhibits the reaction Glucose results in decreased expression of SLC2A2 protein | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Glucose inhibits the reaction SLC2A2 protein results in increased transport of Deoxyglucose | [38] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Glucose inhibits the reaction SLC2A2 protein results in increased transport of Fructose | [38] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation4 |
Glucose results in increased expression of SLC2A2 mRNA | [43] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation5 |
Plant Extracts inhibits the reaction Glucose results in decreased expression of SLC2A2 protein | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation6 |
SLC2A2 protein results in increased transport of Glucose | [42] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
Flame Retardants results in increased abundance of tris(1,3-dichloro-2-propyl)phosphate which results in decreased expression of SLC2A2 protein | [52] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
Benzo(a)pyrene affects the methylation of SLC2A2 promoter | [34] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
4-hydroxyisoleucine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
4-hydroxyisoleucine results in increased phosphorylation of SLC2A2 protein | [30] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
5-iodotubercidin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
5-iodotubercidin results in increased expression of SLC2A2 mRNA | [31] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction SIRT1 protein promotes the reaction Resveratrol results in increased expression of SLC2A2 mRNA | [18] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Acetylcysteine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acetylcysteine inhibits the reaction Pyruvaldehyde affects the localization of SLC2A2 protein | [32] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Bezafibrate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Bezafibrate inhibits the reaction Oleic Acid results in increased expression of SLC2A2 mRNA | [35] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bisphenol A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol A affects the expression of SLC2A2 mRNA | [25] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
caffeic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
caffeic acid results in increased expression of SLC2A2 mRNA | [28] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Catechin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Catechin inhibits the reaction Glucose results in decreased expression of SLC2A2 protein | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
CGP 52608 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
CGP 52608 promotes the reaction RORA protein binds to SLC2A2 gene | [36] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Chenodeoxycholic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid results in decreased expression of SLC2A2 mRNA | [37] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Cytochalasin B |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cytochalasin B inhibits the reaction SLC2A2 protein results in increased transport of Deoxyglucose | [38] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Dehydroascorbic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
SLC2A2 protein results in increased uptake of Dehydroascorbic Acid | [39] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Deoxycholic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid results in decreased expression of SLC2A2 mRNA | [37] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Deoxyglucose |
5 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cytochalasin B inhibits the reaction SLC2A2 protein results in increased transport of Deoxyglucose | [38] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Fructose inhibits the reaction SLC2A2 protein results in increased transport of Deoxyglucose | [38] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Glucose inhibits the reaction SLC2A2 protein results in increased transport of Deoxyglucose | [38] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation4 |
Maltose inhibits the reaction SLC2A2 protein results in increased transport of Deoxyglucose | [38] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation5 |
SLC2A2 protein results in increased transport of Deoxyglucose | [38] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
dicrotophos |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
dicrotophos results in decreased expression of SLC2A2 mRNA | [23] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Diethylnitrosamine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Diethylnitrosamine results in decreased expression of SLC2A2 mRNA | [40] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Fructose |
4 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Fructose inhibits the reaction SLC2A2 protein results in increased transport of Deoxyglucose | [38] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Glucose inhibits the reaction SLC2A2 protein results in increased transport of Fructose | [38] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Maltose inhibits the reaction SLC2A2 protein results in increased transport of Fructose | [38] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation4 |
SLC2A2 protein results in increased transport of Fructose | [42] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Galactose |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
SLC2A2 protein results in increased transport of Galactose | [38] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Glycochenodeoxycholic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid results in decreased expression of SLC2A2 mRNA | [37] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Glycocholic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid results in decreased expression of SLC2A2 mRNA | [37] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Glycodeoxycholic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid results in decreased expression of SLC2A2 mRNA | [37] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
hyperoside |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
hyperoside analog results in increased expression of SLC2A2 mRNA | [28] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
indirubin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
indirubin results in decreased expression of SLC2A2 mRNA | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Maltose |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Maltose inhibits the reaction SLC2A2 protein results in increased transport of Deoxyglucose | [38] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Maltose inhibits the reaction SLC2A2 protein results in increased transport of Fructose | [38] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
methyleugenol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
methyleugenol results in decreased expression of SLC2A2 mRNA | [26] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Okadaic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Okadaic Acid results in decreased expression of SLC2A2 mRNA | [46] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Oleic Acid |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Bezafibrate inhibits the reaction Oleic Acid results in increased expression of SLC2A2 mRNA | [35] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Palmitic Acid co-treated with Oleic Acid results in decreased expression of SLC2A2 mRNA | [47] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Palmitic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Palmitic Acid co-treated with Oleic Acid results in decreased expression of SLC2A2 mRNA | [47] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
perfluorooctane sulfonic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
perfluorooctane sulfonic acid results in decreased expression of SLC2A2 mRNA | [27] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Pyruvaldehyde |
5 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acetylcysteine inhibits the reaction Pyruvaldehyde affects the localization of SLC2A2 protein | [32] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
NFE2L2 protein affects the reaction Resveratrol inhibits the reaction Pyruvaldehyde affects the localization of SLC2A2 protein | [32] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Pyruvaldehyde affects the localization of SLC2A2 protein | [32] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation4 |
Resveratrol inhibits the reaction Pyruvaldehyde affects the localization of SLC2A2 protein | [32] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation5 |
Rosiglitazone inhibits the reaction Pyruvaldehyde affects the localization of SLC2A2 protein | [32] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Rosiglitazone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Rosiglitazone inhibits the reaction Pyruvaldehyde affects the localization of SLC2A2 protein | [32] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
sodium arsenite |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sodium arsenite results in decreased expression of SLC2A2 mRNA | [24] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Tartrazine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Tartrazine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid results in decreased expression of SLC2A2 mRNA | [37] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Tetrachlorodibenzodioxin |
10 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
AHR protein promotes the reaction Tetrachlorodibenzodioxin results in decreased expression of SLC2A2 mRNA | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
ARNT protein promotes the reaction Tetrachlorodibenzodioxin results in decreased expression of SLC2A2 mRNA | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Endosulfan co-treated with Tetrachlorodibenzodioxin results in decreased expression of SLC2A2 mRNA | [41] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation4 |
Endosulfan promotes the reaction Tetrachlorodibenzodioxin results in decreased expression of SLC2A2 mRNA | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation5 |
Tetrachlorodibenzodioxin affects the expression of SLC2A2 mRNA | [50] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation6 |
Tetrachlorodibenzodioxin inhibits the reaction SRC protein results in increased expression of SLC2A2 mRNA | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation7 |
Tetrachlorodibenzodioxin promotes the reaction ARNT protein results in decreased expression of SLC2A2 mRNA | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation8 |
Tetrachlorodibenzodioxin promotes the reaction Endosulfan results in decreased expression of SLC2A2 mRNA | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation9 |
Tetrachlorodibenzodioxin results in decreased expression of SLC2A2 mRNA | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation10 |
Tetrachlorodibenzodioxin results in decreased expression of SLC2A2 protein | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
tributyltin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
tributyltin results in increased expression of SLC2A2 mRNA | [51] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
triphenyl phosphate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Flame Retardants results in increased abundance of triphenyl phosphate which results in decreased expression of SLC2A2 protein | [52] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Vanillic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Vanillic Acid inhibits the reaction INS protein results in decreased expression of SLC2A2 protein | [44] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Herbicide |
|||||
Paraquat |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Paraquat inhibits the reaction SYT1 protein results in increased expression of SLC2A2 protein | [48] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Paraquat results in decreased expression of SLC2A2 protein | [48] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Nanoparticle |
|||||
perfluoro-n-nonanoic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
perfluoro-n-nonanoic acid results in decreased expression of SLC2A2 mRNA | [27] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Approved Drug |
|||||
Copper Sulfate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Copper Sulfate inhibits the expression of SLC2A2 | [1] | |||
Estradiol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Estradiol inhibits the expression of SLC2A2 | [2] | |||
Folic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Folic Acid inhibits the expression of SLC2A2 | [3] | |||
Hydrogen Peroxide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Hydrogen Peroxide inhibits the expression of SLC2A2 | [4] | |||
Arsenic Trioxide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Arsenic Trioxide increases the expression of SLC2A2 | [5] | |||
Azathioprine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Azathioprine inhibits the expression of SLC2A2 | [6] | |||
Methotrexate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Methotrexate increases the expression of SLC2A2 | [7] | |||
Atorvastatin |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Atorvastatin inhibits the expression of SLC2A2 | [8] | |||
DT Modulation2 |
NR1I2 protein promotes the reaction Atorvastatin results in decreased expression of SLC2A2 protein | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Urethane |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Urethane inhibits the expression of SLC2A2 | [9] | |||
Valproic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Valproic Acid inhibits the expression of SLC2A2 | [10] | |||
Calcitriol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Calcitriol inhibits the expression of SLC2A2 | [11] | |||
Cyclosporine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cyclosporine inhibits the expression of SLC2A2 | [12] | |||
Acetaminophen |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acetaminophen inhibits the expression of SLC2A2 | [13] | |||
Rifampin |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Rifampin inhibits the expression of SLC2A2 | [14] | |||
Pentoxifylline |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Pentoxifylline induces the activity of SLC2A2 | [15] | |||
Metformin |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Metformin inhibits the reaction INS protein results in decreased expression of SLC2A2 protein | [44] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Metformin results in increased phosphorylation of SLC2A2 protein | [30] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
SLC2A2 intron SNP results in increased susceptibility to Metformin | [45] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Drug in Phase 3 Trial |
|||||
Resveratrol |
5 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Resveratrol increases the expression of SLC2A2 | [18] | |||
Drug in Phase 2 Trial |
|||||
Bisphenol A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Bisphenol A affects the expression of SLC2A2 | [25] | |||
Drug in Phase 1 Trial |
|||||
Quercetin |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Quercetin inhibits the expression of SLC2A2 | [19] | |||
Sodium arsenite |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Sodium arsenite inhibits the expression of SLC2A2 | [24] | |||
Drug in Preclinical Test |
|||||
DT Modulation1 |
Oleic Acid increases the expression of SLC2A2 | [54] | |||
Regulation Mechanism |
via enhancement of Peroxisome proliferator-activated receptor alpha (PPARA) | Transcription Factor Info | |||
Affected Drug/Substrate |
Insulin | Modulation Type | Inducer | ||
Cell System |
Human hepatoblastoma cells (HepG2) | ||||
Investigative Drug |
|||||
Glucose |
7 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Glucose inhibits the expression of SLC2A2 | [21] | |||
Natural Product |
|||||
Indirubin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Indirubin inhibits the expression of SLC2A2 | [16] | |||
Coal Ash |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Coal Ash increases the expression of SLC2A2 | [17] | |||
DT Modulation1 |
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction SIRT1 protein promotes the reaction Resveratrol results in increased expression of SLC2A2 mRNA | [18] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
NFE2L2 protein affects the reaction Resveratrol inhibits the reaction Pyruvaldehyde affects the localization of SLC2A2 protein | [32] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Resveratrol inhibits the reaction Pyruvaldehyde affects the localization of SLC2A2 protein | [32] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation4 |
SIRT1 protein promotes the reaction Resveratrol results in increased expression of SLC2A2 mRNA | [18] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
Quercetin results in decreased activity of SLC2A2 protein | [49] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Phloretin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Phloretin inhibits the expression of SLC2A2 | [8] | |||
Methyleugenol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Methyleugenol inhibits the expression of SLC2A2 | [26] | |||
Hyperoside |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Hyperoside increases the expression of SLC2A2 | [28] | |||
Environmental toxicant |
|||||
Polychlorinated dibenzodioxin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Polychlorinated dibenzodioxin inhibits the expression of SLC2A2 | [29] | |||
Mycotoxins |
|||||
Aflatoxin B1 |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Aflatoxin B1 inhibits the expression of SLC2A2 | [20] | |||
DT Modulation2 |
Aflatoxin B1 affects the expression of SLC2A2 protein | [2] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Aflatoxin B1 results in decreased methylation of SLC2A2 gene | [33] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Zearalenone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Zearalenone results in increased expression of SLC2A2 mRNA | [53] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Carcinogen |
|||||
Benzo(a)pyrene |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Benzo(a)pyrene inhibits the expression of SLC2A2 | [26] | |||
Pesticide/Insecticide |
|||||
Dicrotophos |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Dicrotophos inhibits the expression of SLC2A2 | [23] | |||
Endosulfan |
4 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Endosulfan inhibits the expression of SLC2A2 | [29] | |||
Health and Environmental Toxicant |
|||||
tris(1,3-dichloro-2-propyl)phosphate |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
tris(1,3-dichloro-2-propyl)phosphate inhibits the expression of SLC2A2 | [22] | |||
Perfluorooctane sulfonic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Perfluorooctane sulfonic acid inhibits the expression of SLC2A2 | [27] | |||
Caffeic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Caffeic acid increases the expression of SLC2A2 | [28] | |||
DT Modulation1 |
Endosulfan co-treated with Tetrachlorodibenzodioxin results in decreased expression of SLC2A2 mRNA | [41] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Endosulfan promotes the reaction Tetrachlorodibenzodioxin results in decreased expression of SLC2A2 mRNA | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Tetrachlorodibenzodioxin promotes the reaction Endosulfan results in decreased expression of SLC2A2 mRNA | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.